Molecule intelOpportunity: Moderate0

Cranberry Extract

14 brands · 8 companies · product forms

Opportunity snapshot

Launch attractiveness
39
Market saturation
22
Price room
100
Regulatory risk
0
14
brands
8
companies
Rs 504.45
median price
7
price points
15.35x
price spread
90
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 7%

1 brands · 7%
1 brands · 7%
1 brands · 7%
1 brands · 7%

Price room

Across observed sources and strengths
CheapestRs 61.52
MedianRs 504.45
Most expensiveRs 944.3
Spread15.35×
Sources: DVAGO, Servaid

max/min price ratio 15.35x across 7 trusted points (Rs 61.52-944.3). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 9 live products for Cranberry Extract — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(0) + 25% price-variation(100) + 20% low-competition(78) + 15% supply-disruption(0), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

8 canonical companies and 14 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 15.35x across 7 trusted points (Rs 61.52-944.3). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Reduced by: no ATC code.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.